Embecta Corp.
EMBC • NASDAQ
Embecta Corp. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Devdatt Kurdikar, with a market cap of $525.3M.
Market Cap$525.3M
Employees2.2K
CEODevdatt Kurdikar
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 8, 2026 · In 3 weeksQ2 2026
Financials
Embecta Corp. FAQ
Common questions about Embecta Corp.
Embecta Corp. is scheduled to report earnings for Q2 2026 on May 8, 2026. Analysts estimate revenue of $235.7M.
Embecta Corp. has approximately 2,200 employees.